Domain Associates Closes Latest Life Sciences Venture Capital Fund, at $163.6M

domain_associatesDomain Associates, a San Diego, CA and Princeton, NJ-based venture capital firm focused on the life sciences sector, closed its latest fund at $163.6m.

According to a regulatory form filed with the SEC, Domain Partners IX, L.P. was subscribed by 6 investors.

The document lists partners Jim Blair, Brian Dovey, Brian Halak, Nicole Vitullo, and Kim Kamdar as people related to the offering.

Founded in 1985, Domain has been involved in the formation of more than 260 life sciences companies developing therapeutics and medical devices, clinical diagnostics, tools and instrumentations and healthcare information technologies that better manage care and costs.
The firm typically invests in the first institutional financing round of a company but also gives support at later stages, including into public companies.
Current portfolio companies include Achillon, Cartiva, Cotera, Esporion Therapeutics, Fractyl, Neuropace, Orexigen, Rox Medical, Veracyte, Zyga, etc.



Join the discussion